Contact
For more information or if you have any questions, please contact the Commission’s QUM Customer Service team at QUMCustomerService@safetyandquality.gov.au
Transition of Quality Use of Medicines programs
From 1 January 2023, the Commission became the custodian of Quality Use of Medicines (QUM) functions, including QUM Stewardship. This follows the redesign of the Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program outlined in the 2022–23 Federal Budget.
The functions that transitioned to the Commission and their current status are outlined below.
Overview
Under the redesigned QUDTP Program, the Commission is responsible for a range of QUM functions, including QUM stewardship. This includes the maintenance of some materials and resources previously developed by NPS MedicineWise.
The Commission recognises the expertise and commitment of NPS MedicineWise staff and acknowledges the significant contribution of NPS MedicineWise to Australia’s health system. Our organisations worked together closely during the initial transition period to support continued access to QUDTP funded materials and resources. Throughout the next phase of the transition, the Commission will engage with consumers, clinicians and policy experts, and will provide further information as the work progresses.
QUM stewardship seeks to foster the appropriate, safe and effective use of medicines. This QUM work is an extension of the Commission’s existing Medication Safety program and complements previous work including the National Indicators for Quality Use of Medicines in Australian Hospitals and the National Baseline Report on Quality Use of Medicines and Medicines Safety – Phase 1 Residential aged care.